research 173 Impact of Clinical Severity on Absenteeism and Presenteeism in Patients with Hidradenitis Suppurativa
Severe Hidradenitis Suppurativa increases missed and unproductive workdays.
Search
forResearch
5 / 1000+ results 
research Stromal vascular fraction‐enriched platelet‐rich plasma therapy reverses the effects of androgenetic alopecia
SVF-PRP therapy effectively reverses hair loss effects.
research Reliability and Validity of a Photographic Method for Measuring Facial Hair Density in Men
The photographic method for measuring facial hair density is reliable and valid but needs further testing on different hair densities and skin colors.
research Effectiveness and Safety of Topical Finasteride for Male Androgenetic Alopecia: Real World Data
Topical finasteride effectively and safely improves hair growth in men with androgenetic alopecia.
research Is topical eflornithine an effective adjunctive therapy in reducing unwanted facial hair in women diagnosed with hirsutism
Topical eflornithine effectively reduces unwanted facial hair in women with hirsutism for at least 6 months.
Community Join
3 / 1000+ resultscommunity Evidenced Based Meta-Analyses and Systemic Reviews of Androgenic Alopecia and Treatments
Evidence-based treatments for androgenic alopecia, such as minoxidil, finasteride, low-level laser light therapy, dutasteride, platelet-rich plasma, and topical ketoconazole. It discusses the efficacy, safety, and mechanism of action of these treatments, as well as future developments in understanding this polygenic condition.
community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied
Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.
community Breezula Phase III 12-Month Data Released by Cosmo Pharma
Clascoterone 5% topical solution is effective and safe for long-term use in treating male pattern hair loss. Cosmo Pharma aims for EU and US approval, with a potential US release in late 2027 or early 2028.
Clinics
6 / 10 results- 50
Hair TransplantHair Loss TreatmentsSMPPhysicians Hair InstituteParadise Valley, AZ · US - 27Hair Loss TreatmentsPhysicians Med SpaMilford, CT · US
- 47
Hair TransplantHair Loss TreatmentsSkin Physiciansnull, AB · CA - 33
Hair Loss TreatmentsHair TransplantDermatologyDermcare Physicians and SurgeonsArlington, MA · US - 11Hair Loss TreatmentsSkin PhysiciansHuddersfield · GB
- 5Hair Loss TreatmentsSkinCare PhysiciansChestnut Hill, MA · US
Learn
— no results
Experts
— no results